(Patho)physiology of cross-sex hormone administration to transsexual people: The potential impact of male-female genetic differences

Andrologia

Volumn 47, Issue 1, 2015, Pages 5-19

  Gooren, L J ^a,b   Kreukels, B ^a   Lapauw, B ^c   Giltay, E J ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Androconsult   (Thailand)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone; Cardiovascular disease; Cross sex hormones; Genomic effects; Transsexualism

Indexed keywords

MICRORNA; SEX HORMONE; ANDROGEN; ESTROGEN;

AUTOIMMUNE DISEASE; AUTOSOME; BRAIN FUNCTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; EPIGENETICS; FEMALE; FRACTURE; GENETIC DIFFERENCE; GENETICS; HORMONAL REGULATION; HUMAN; IMMUNOLOGY; MALE; MALE TO FEMALE TRANSGENDER; METABOLISM; OSTEOPOROSIS; REVIEW; SEX DIFFERENCE; SEX REASSIGNMENT; X CHROMOSOME; Y CHROMOSOME; BONE; BRAIN; DRUG EFFECTS; FRAGILITY FRACTURE; IMMUNE SYSTEM; TRANSGENDER;

ANDROGENS; BONE AND BONES; BRAIN; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; ESTROGENS; FEMALE; HUMANS; IMMUNE SYSTEM; MALE; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; SEX FACTORS; TRANSGENDERED PERSONS;

EID: 84921027036     PISSN: 03034569     EISSN: 14390272     Source Type: Journal    
DOI: 10.1111/and.12389     Document Type: Review

References (122)

1. Arnold AP (2009) Mouse models for evaluating sex chromosome effects that cause sex differences in non-gonadal tissues. J Neuroendocrinol 21:377-386.
2. Arnold AP, Chen X (2009) What does the "four core genotypes" mouse model tell us about sex differences in the brain and other tissues? Front Neuroendocrinol 30:1-9.
3. Asscheman H, Giltay EJ, Megens JA, de Ronde WP, van Trotsenburg MA, Gooren LJ (2011) A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol 164:635-642.
4. Avner P, Heard E (2001) X-chromosome inactivation: counting, choice and initiation. Nat Rev Genet 2:59-67.
5. Banks SJ, Jones-Gotman M, Ladowski D, Sziklas V (2012) Sex differences in the medial temporal lobe during encoding and recognition of pseudowords and abstract designs. Neuroimage 59:1888-1895.
6. Black BE, Vitto MJ, Gioeli D, Spencer A, Afshar N, Conaway MR, Weber MJ, Paschal BM (2004) Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions. Mol Endocrinol 18:834-850.
7. Butterworth M, McClellan B, Allansmith M (1967) Influence of sex in immunoglobulin levels. Nature 214:1224-1225.
8. Callewaert F, Venken K, Ophoff J, De Gendt K, Torcasio A, van Lenthe GH, Van Oosterwyck H, Boonen S, Bouillon R, Verhoeven G, Vanderschueren D (2009) Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-alpha. FASEB J 23:232-240.
9. Carnevale V, Nieddu L, Romagnoli E, Bona E, Piemonte S, Scillitani A, Minisola S (2006) Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey. Osteoporos Int 17:478-483.
10. Cawthon PM (2011) Gender differences in osteoporosis and fractures. Clin Orthop Relat Res 469:1900-1905.
11. Chan KL, Mok CC (2013) Development of systemic lupus erythematosus in a male-to-female transsexual: the role of sex hormones revisited. Lupus 22:1399-1402.
12. Chen Q, Kaji H, Kanatani M, Sugimoto T, Chihara K (2004) Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells. Horm Metab Res 36:674-678.
13. Coutinho ES, Fletcher A, Bloch KV, Rodrigues LC (2008) Risk factors for falls with severe fracture in elderly people living in a middle-income country: a case control study. BMC Geriatr 8:21.
14. Crabbe P, Bogaert V, De Bacquer D, Goemaere S, Zmierczak H, Kaufman JM (2007) Part of the interindividual variation in serum testosterone levels in healthy men reflects differences in androgen sensitivity and feedback set point: contribution of the androgen receptor polyglutamine tract polymorphism. J Clin Endocrinol Metab 92:3604-3610.
15. Delemarre-van de Waal H, Cohen-Kettenis PT (2006) Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects. Eur J Endocrinol 155:131-137.
16. van Dijk FS, Zillikens MC, Micha D, Riessland M, Marcelis CL, de Die-Smulders CE, Milbradt J, Franken AA, Harsevoort AJ, Lichtenbelt KD, Pruijs HE, Rubio-Gozalbo ME, Zwertbroek R, Moutaouakil Y, Egthuijsen J, Hammerschmidt M, Bijman R, Semeins CM, Bakker AD, Everts V, Klein-Nulend J, Campos-Obando N, Hofman A, te Meerman GJ, Verkerk AJ, Uitterlinden AG, Maugeri A, Sistermans EA, Waisfisz Q, Meijers-Heijboer H, Wirth B, Simon ME, Pals G (2013) PLS3 mutations in X-linked osteoporosis with fractures. N Engl J Med 369:1529-1536.
17. Dittrich R, Binder H, Cupisti S, Hoffmann I, Beckmann MW, Mueller A (2005) Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist. Exp Clin Endocrinol Diabetes 113:586-592.
18. Eidinger D, Garrett TJ (1972) Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation. J Exp Med 136:1098-1116.
19. Elbers JM, Asscheman H, Seidell JC, Frolich M, Meinders AE, Gooren LJ (1997) Reversal of the sex difference in serum leptin levels upon cross-sex hormone administration in transsexuals. J Clin Endocrinol Metab 82:3267-3270.
20. Endo Y, Aharonoff GB, Zuckerman JD, Egol KA, Koval KJ (2005) Gender differences in patients with hip fracture: a greater risk of morbidity and mortality in men. J Orthop Trauma 19:29-35.
21. Fahiminiya S, Majewski J, Al-Jallad H, Moffatt P, Mort J, Glorieux FH, Roschger P, Klaushofer K, Rauch F (2014) Osteoporosis caused by mutations in PLS3: clinical and bone tissue characteristics. J Bone Miner Res 29:1805-1814.
22. Fairweather D, Frisancho-Kiss S, Rose NR (2008) Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 173:600-609.
23. Fine C, Jordan-Young R, Kaiser A, Rippon G (2013) Plasticity, plasticity, plasticity ... and the rigid problem of sex. Trends Cogn Sci 17:550-551.
24. Fuente-Martin E, Argente-Arizon P, Ros P, Argente J, Chowen JA (2013) Sex differences in adipose tissue: it is not only a question of quantity and distribution. Adipocyte 2:128-134.
25. Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD (1996) Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11:337-349.
26. Geusens P, Dinant G (2007) Integrating a gender dimension into osteoporosis and fracture risk research. Gend Med 4(Suppl B):S147-S161.
27. Giedd JN, Raznahan A, Mills KL, Lenroot RK (2012) Review: magnetic resonance imaging of male/female differences in human adolescent brain anatomy. Biol Sex Differ 3:19.
28. Giltay EJ, Fonk JC, von Blomberg BM, Drexhage HA, Schalkwijk C, Gooren LJ (2000a) In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab 85:1648-1657.
29. Giltay EJ, Gooren LJ, Emeis JJ, Kooistra T, Stehouwer CD (2000b) Oral ethinyl estradiol, but not transdermal 17beta-estradiol, increases plasma C-reactive protein levels in men. Thromb Haemost 84:359-360.
30. Giltay EJ, Kho KH, Blansjaar BA, Verbeek MM, Geurtz PB, Geleijnse JM, Gooren LJ (2005) The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects. J Endocrinol 187:109-116.
31. Gomez-Gil E, Canizares S, Torres A, de la Torre F, Halperin I, Salamero M (2009) Androgen treatment effects on memory in female-to-male transsexuals. Psychoneuroendocrinology 34:110-117.
32. Gooren LJ (2011) Clinical practice. Care of transsexual persons. N Engl J Med 364:1251-1257.
33. Gooren LJ, Giltay EJ (2014) Men and women, so different, so similar: observations from cross-sex hormone treatment of transsexual subjects. Andrologia 46:570-575.
34. Gooren L, Lips P (2014) Conjectures concerning cross-sex hormone treatment of aging transsexual persons. J Sex Med 11:2012-2019.
35. Gooren LJ, Wierckx K, Giltay EJ (2014) Cardiovascular disease in transsexual persons treated with cross-sex hormones: reversal of the traditional sex difference in cardiovascular disease pattern. Eur J Endocrinol 170:809-819.
36. van Goozen SH, Slabbekoorn D, Gooren LJ, Sanders G, Cohen-Kettenis PT (2002) Organizing and activating effects of sex hormones in homosexual transsexuals. Behav Neurosci 116:982-988.
37. Granacher U, Gollhofer A, Hortobagyi T, Kressig RW, Muehlbauer T (2013) The importance of trunk muscle strength for balance, functional performance, and fall prevention in seniors: a systematic review. Sports Med 43:627-641.
38. Grundbacher FJ (1972) Human X chromosome carries quantitative genes for immunoglobulin M. Science 176:311-312.
39. Halpern D (2012) Sex Differences in Cognitive Abilities. Psychology Press, New York, NY.
40. Haraldsen IR, Egeland T, Haug E, Finset A, Opjordsmoen S (2005) Cross-sex hormone treatment does not change sex-sensitive cognitive performance in gender identity disorder patients. Psychiatry Res 137:161-174.
41. Haraldsen IR, Haug E, Falch J, Egeland T, Opjordsmoen S (2007) Cross-sex pattern of bone mineral density in early onset gender identity disorder. Horm Behav 52:334-343.
42. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, Gooren LJ, Meyer WJ 3rd, Spack NP, Tangpricha V, Montori VM (2009) Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 94:3132-3154.
43. Holterhus PM (2011) Molecular androgen memory in sex development. Pediatr Endocrinol Rev 9(Suppl 1):515-518.
44. Hulshoff Pol HE, Cohen-Kettenis PT, Van Haren NEM, Peper JS, Brans RGH, Cahn W, Schnack HG, Gooren LJ, Kahn RS (2006) Changing your sex changes your brain: influences of testosterone and estrogen on adult human brain structure. Eur J Endocrinol 155:S107-S114.
45. Huxley VH (2007) Sex and the cardiovascular system: the intriguing tale of how women and men regulate cardiovascular function differently. Adv Physiol Educ 31:17-22.
46. Ingalhalikar M, Smith A, Parker D, Satterthwaite TD, Elliott MA, Ruparel K, Hakonarson H, Gur RE, Gur RC, Verma R (2014) Sex differences in the structural connectome of the human brain. Proc Natl Acad Sci USA 111:823-828.
47. Kacar S, Akdogan M, Kosar Y, Parlak E, Sasmaz N, Oguz P, Aydog G (2002) Estrogen and cyproterone acetate combination-induced autoimmune hepatitis. J Clin Gastroenterol 35:98-100.
48. Kallel I, Rebai M, Rebai A (2012) Mutations and polymorphisms of estrogens receptors genes and diseases susceptibility. J Recept Signal Transduct Res 32:304-313.
49. Kaufman JM, Reginster JY, Boonen S, Brandi ML, Cooper C, Dere W, Devogelaer JP, Diez-Perez A, Kanis JA, McCloskey E, Mitlak B, Orwoll E, Ringe JD, Weryha G, Rizzoli R (2013) Treatment of osteoporosis in men. Bone 53:134-144.
50. Kelly TN, Rebholz CM, Gu D, Hixson JE, Rice TK, Cao J, Chen J, Li J, Lu F, Ma J, Mu J, Whelton PK, He J (2013) Analysis of sex hormone genes reveals gender differences in the genetic etiology of blood pressure salt sensitivity: the GenSalt study. Am J Hypertens 26:191-200.
51. Koreen AR, Lieberman J, Alvir J, Mayerhoff D, Loebel A, Chakos M, Amin F, Cooper T (1994) Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response. Arch Gen Psychiatry 51:132-138.
52. Kudlacek S, Schneider B, Resch H, Freudenthaler O, Willvonseder R (2000) Gender differences in fracture risk and bone mineral density. Maturitas 36:173-180.
53. Lapauw B, Taes Y, Simoens S, Van Caenegem E, Weyers S, Goemaere S, Toye K, Kaufman JM, T'Sjoen GG (2008) Body composition, volumetric and areal bone parameters in male-to-female transsexual persons. Bone 43:1016-1021.
54. Lapauw BM, Taes Y, Bogaert V, Vanbillemont G, Goemaere S, Zmierczak HG, De Bacquer D, Kaufman JM (2009) Serum estradiol is associated with volumetric BMD and modulates the impact of physical activity on bone size at the age of peak bone mass: a study in healthy male siblings. J Bone Miner Res 24:1075-1085.
55. Lenarz C, Shishani Y, McCrum C, Nowinski RJ, Edwards TB, Gobezie R (2011) Is reverse shoulder arthroplasty appropriate for the treatment of fractures in the older patient? Early observations. Clin Orthop Relat Res 469:3324-3331.
56. Lentini E, Kasahara M, Arver S, Savic I (2013) Sex differences in the human brain and the impact of sex chromosomes and sex hormones. Cereb Cortex 23:2322-2336.
57. Lenz KM, McCarthy MM (2014) A starring role for microglia in brain sex differences. Neuroscientist 2014. pii: 1073858414536468. [Epub ahead of print].
58. Lichtman MA, Vaughan JH, Hames CG (1967) The distribution of serum immunoglobulins, anti-gamma-G globulins ("rheumatoid factors") and antinuclear antibodies in White and Negro subjects in Evans County, Georgia. Arthritis Rheum 10:204-215.
59. Lim S, Joung H, Shin CS, Lee HK, Kim KS, Shin EK, Kim HY, Lim MK, Cho SI (2004) Body composition changes with age have gender-specific impacts on bone mineral density. Bone 35:792-798.
60. Link JC, Chen X, Arnold AP, Reue K (2013) Metabolic impact of sex chromosomes. Adipocyte 2:74-79.
61. Lips P, van Kesteren PJ, Asscheman H, Gooren LJ (1996) The effect of androgen treatment on bone metabolism in female-to-male transsexuals. J Bone Miner Res 11:1769-1773.
62. Liu PY, Death AK, Handelsman DJ (2003) Androgens and cardiovascular disease. Endocr Rev 24:313-340.
63. Maas AH, Appelman YE (2010) Gender differences in coronary heart disease. Neth Heart J 18:598-603.
64. Martin-Subero JI (2011) How epigenomics brings phenotype into being. Pediatr Endocrinol Rev 9(Suppl 1):506-510.
65. McCarthy MM, Arnold AP, Ball GF, Blaustein JD, De Vries GJ (2012) Sex differences in the brain: the not so inconvenient truth. J Neurosci 32:2241-2247.
66. Mendelsohn ME, Karas RH (2005) Molecular and cellular basis of cardiovascular gender differences. Science 308:1583-1587.
67. Michael H, Harkonen PL, Vaananen HK, Hentunen TA (2005) Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption. J Bone Miner Res 20:2224-2232.
68. Miles C, Green R, Hines M (2006) Estrogen treatment effects on cognition, memory and mood in male-to-female transsexuals. Horm Behav 50:708-717.
69. Miller VM (2010) Sex-based differences in vascular function. Womens Health (Lond Engl) 6:737-752.
70. Mueller A, Dittrich R, Binder H, Kuehnel W, Maltaris T, Hoffmann I, Beckmann MW (2005) High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone. Eur J Endocrinol 153:107-113.
71. Mueller A, Haeberle L, Zollver H, Claassen T, Kronawitter D, Oppelt PG, Cupisti S, Beckmann MW, Dittrich R (2010) Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals. J Sex Med 7:3190-3198.
72. Narkiewicz K, Phillips BG, Kato M, Hering D, Bieniaszewski L, Somers VK (2005) Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 45:522-525.
73. Ngun TC, Ghahramani N, Sanchez FJ, Bocklandt S, Vilain E (2011) The genetics of sex differences in brain and behavior. Front Neuroendocrinol 32:227-246.
74. Nielsen TF, Ravn P, Bagger YZ, Warming L, Christiansen C (2004) Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study. Osteoporos Int 15:168-174.
75. Nussinovitch U, Shoenfeld Y (2012) The role of gender and organ specific autoimmunity. Autoimmun Rev 11:A377-A385.
76. Oskui PM, French WJ, Herring MJ, Mayeda GS, Burstein S, Kloner RA (2013) Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. J Am Heart Assoc 2:e000272.
77. Oyen J, Gram Gjesdal C, Nygard OK, Lie SA, Meyer HE, Apalset EM, Ueland PM, Pedersen ER, Midttun O, Vollset SE, Tell GS (2014) Smoking and body fat mass in relation to bone mineral density and hip fracture: the Hordaland Health Study. PLoS One 9:e92882.
78. Pennell LM, Galligan CL, Fish EN (2012) Sex affects immunity. J Autoimmun 38:J282-J291.
79. Phoenix CH (2009) Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Horm Behav 55:566.
80. Rametti G, Carrillo B, Gomez-Gil E, Junque C, Zubiaurre-Elorza L, Segovia S, Gomez A, Karadi K, Guillamon A (2012) Effects of androgenization on the white matter microstructure of female-to-male transsexuals. A diffusion tensor imaging study. Psychoneuroendocrinology 37:1261-1269.
81. Rana BK, Insel PA, Payne SH, Abel K, Beutler E, Ziegler MG, Schork NJ, O'Connor DT (2007) Population-based sample reveals gene-gender interactions in blood pressure in White Americans. Hypertension 49:96-106.
82. Reblin M, Uchino BN (2008) Social and emotional support and its implication for health. Curr Opin Psychiatry 21:201-205.
83. Regitz-Zagrosek V (2006) Therapeutic implications of the gender-specific aspects of cardiovascular disease. Nat Rev Drug Discov 5:425-438.
84. Reutrakul S, Ongphiphadhanakul B, Piaseu N, Krittiyawong S, Chanprasertyothin S, Bunnag P, Rajatanavin R (1998) The effects of oestrogen exposure on bone mass in male to female transsexuals. Clin Endocrinol (Oxf) 49:811-814.
85. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195-2207.
86. Ring HZ, Lessov CN, Reed T, Marcus R, Holloway L, Swan GE, Carmelli D (2005) Heritability of plasma sex hormones and hormone binding globulin in adult male twins. J Clin Endocrinol Metab 90:3653-3658.
87. Ruetsche AG, Kneubuehl R, Birkhaeuser MH, Lippuner K (2005) Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study. Osteoporos Int 16:791-798.
88. Saika M, Inoue D, Kido S, Matsumoto T (2001) 17beta-estradiol stimulates expression of osteoprotegerin by a mouse stromal cell line, ST-2, via estrogen receptor-alpha. Endocrinology 142:2205-2212.
89. Sakiani S, Olsen NJ, Kovacs WJ (2013) Gonadal steroids and humoral immunity. Nat Rev Endocrinol 9:56-62.
90. Schlatterer K, Auer DP, Yassouridis A, von Werder K, Stalla GK (1998) Transsexualism and osteoporosis. Exp Clin Endocrinol Diabetes 106:365-368.
91. Schoning S, Engelien A, Kugel H, Schafer S, Schiffbauer H, Zwitserlood P, Pletziger E, Beizai P, Kersting A, Ohrmann P, Greb RR, Lehmann W, Heindel W, Arolt V, Konrad C (2007) Functional anatomy of visuo-spatial working memory during mental rotation is influenced by sex, menstrual cycle, and sex steroid hormones. Neuropsychologia 45:3203-3214.
92. Schoning S, Engelien A, Bauer C, Kugel H, Kersting A, Roestel C, Zwitserlood P, Pyka M, Dannlowski U, Lehmann W, Heindel W, Arolt V, Konrad C (2010) Neuroimaging differences in spatial cognition between men and male-to-female transsexuals before and during hormone therapy. J Sex Med 7:1858-1867.
93. Sharma S, Eghbali M (2014) Influence of sex differences on microRNA gene regulation in disease. Biol Sex Differ 5:3.
94. Simanainen U, Brogley M, Gao YR, Jimenez M, Harwood DT, Handelsman DJ, Robins DM (2011) Length of the human androgen receptor glutamine tract determines androgen sensitivity in vivo. Mol Cell Endocrinol 342:81-86.
95. Simon L, Kozak LR, Simon V, Czobor P, Unoka Z, Szabo A, Csukly G (2013) Regional grey matter structure differences between transsexuals and healthy controls-a voxel based morphometry study. PLoS One 8:e83947.
96. Slabbekoorn D, van Goozen SH, Megens J, Gooren LJ, Cohen-Kettenis PT (1999) Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals. Psychoneuroendocrinology 24:423-447.
97. Steensma TD, Kreukels BP, de Vries AL, Cohen-Kettenis PT (2013) Gender identity development in adolescence. Horm Behav 64:288-297.
98. Stoch SA, Parker RA, Chen L, Bubley G, Ko YJ, Vincelette A, Greenspan SL (2001) Bone loss in men with prostate cancer treated with gonadotropin-releasing hormone agonists. J Clin Endocrinol Metab 86:2787-2791.
99. Straface E, Gambardella L, Brandani M, Malorni W (2012) Sex differences at cellular level: "cells have a sex". Handb Exp Pharmacol 2012:49-65.
100. Sumiyoshi T, Hasegawa M, Jayathilake K, Meltzer HY (1997) Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine. Psychiatry Res 69:113-121.
101. Taes Y, Lapauw B, Vanbillemont G, Bogaert V, De Bacquer D, Goemaere S, Zmierczak H, Kaufman JM (2010) Early smoking is associated with peak bone mass and prevalent fractures in young, healthy men. J Bone Miner Res 25:379-387.
102. Travison TG, Zhuang WV, Lunetta KL, Karasik D, Bhasin S, Kiel DP, Coviello AD, Murabito JM (2014) The heritability of circulating testosterone, oestradiol, oestrone and sex hormone binding globulin concentrations in men: the Framingham Heart Study. Clin Endocrinol (Oxf) 80:277-282.
103. T'Sjoen G, Weyers S, Taes Y, Lapauw B, Toye K, Goemaere S, Kaufman JM (2009) Prevalence of low bone mass in relation to estrogen treatment and body composition in male-to-female transsexual persons. J Clin Densitom 12:306-313.
104. Turner A, Chen TC, Barber TW, Malabanan AO, Holick MF, Tangpricha V (2004) Testosterone increases bone mineral density in female-to-male transsexuals: a case series of 15 subjects. Clin Endocrinol (Oxf) 61:560-566.
105. Turner ME, Farkas J, Dunmire J, Ely D, Milsted A (2009) Which Sry locus is the hypertensive Y chromosome locus? Hypertension 53:430-435.
106. Ukkola O, Gagnon J, Rankinen T, Thompson PA, Hong Y, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C (2001) Age, body mass index, race and other determinants of steroid hormone variability: the HERITAGE Family Study. Eur J Endocrinol 145:1-9.
107. Van Caenegem E, Wierckx K, Taes Y, Dedecker D, Van de Peer F, Toye K, Kaufman JM, T'Sjoen G (2012) Bone mass, bone geometry, and body composition in female-to-male transsexual persons after long-term cross-sex hormonal therapy. J Clin Endocrinol Metab 97:2503-2511.
108. Van Caenegem E, Taes Y, Wierckx K, Vandewalle S, Toye K, Kaufman JM, Schreiner T, Haraldsen I, T'Sjoen G (2013) Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy. Bone 54:92-97.
109. Van Goozen SH, Cohen-Kettenis PT, Gooren LJ, Frijda NH, Van de Poll NE (1995) Gender differences in behaviour: activating effects of cross-sex hormones. Psychoneuroendocrinology 20:343-363.
110. Van Kesteren P, Lips P, Deville W, Popp-Snijders C, Asscheman H, Megens J, Gooren L (1996) The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals. J Clin Endocrinol Metab 81:2227-2232.
111. Van Kesteren P, Lips P, Gooren LJ, Asscheman H, Megens J (1998) Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. Clin Endocrinol (Oxf) 48:347-354.
112. Wachs TD, Georgieff M, Cusick S, McEwen BS (2014) Issues in the timing of integrated early interventions: contributions from nutrition, neuroscience, and psychological research. Ann N Y Acad Sci 1308:89-106.
113. Wagner H, Melhus H, Pedersen NL, Michaelsson K (2013) Genetic influence on bone phenotypes and body composition: a Swedish twin study. J Bone Miner Metab 31:681-689.
114. Wang J, Bingaman S, Huxley VH (2010a) Sex differences in white adipose tissue (WAT) and how this may affect the differential responses of males and females to some metabolic challenges. Am J Physiol Heart Circ Physiol 298:H1146-H1154.
115. Wang J, Bingaman S, Huxley VH (2010b) Intrinsic sex-specific differences in microvascular endothelial cell phosphodiesterases. Am J Physiol Heart Circ Physiol 298:H1146-H1154.
116. Weden MM, Brown RA (2006) Historical and life course timing of the male mortality disadvantage in Europe: epidemiologic transitions, evolution, and behavior. Soc Biol 53:61-80.
117. Wierckx K, Mueller S, Weyers S, Van Caenegem E, Roef G, Heylens G, T'Sjoen G (2012) Long-term evaluation of cross-sex hormone treatment in transsexual persons. J Sex Med 9:2641-2651.
118. Wierckx K, Elaut E, Declercq E, Heylens G, De Cuypere G, Taes Y, Kaufman JM, T'Sjoen G (2013) Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study. Eur J Endocrinol 169:471-478.
119. Wilson R, Spiers A, Ewan J, Johnson P, Jenkins C, Carr S (2009) Effects of high dose oestrogen therapy on circulating inflammatory markers. Maturitas 62:281-286.
120. Yang X, Schadt EE, Wang S, Wang H, Arnold AP, Ingram-Drake L, Drake TA, Lusis AJ (2006) Tissue-specific expression and regulation of sexually dimorphic genes in mice. Genome Res 16:995-1004.
121. Zandman-Goddard G, Solomon M, Barzilai A, Shoenfeld Y (2007) Lupus erythematosus tumidus induced by sex reassignment surgery. J Rheumatol 34:1938-1940.
122. Zubiaurre-Elorza L, Junque C, Gomez-Gil E, Guillamon A (2014) Effects of cross-sex hormone treatment on cortical thickness in transsexual individuals. J Sex Med 11:1248-1261.